王宁远,王威,辛倩,高磊

• 1:中国人民解放军总医院第六医学中心心血管病医学部

摘要(Abstract)：

临床中约10%的患者在接触碘对比剂后会发生对比剂肾病，而对于既往存在肾功能不全者对比剂肾病的发生率可高达40%。严重的对比剂肾病会导致肾功能短时间内急剧恶化，从而诱发严重的不良临床事件。目前临床上已有多种策略可用于预防对比剂肾病的发生，其中减少碘对比剂的剂量是避免对比剂肾病发生的关键。基于此有学者提出了“极低碘对比剂”指导经皮冠状动脉介入治疗这一策略，旨在最大程度减少冠状动脉介入术中碘对比剂的用量。本文就该策略作一综述。

关键词(KeyWords)： 极低碘对比剂;对比剂肾病;经皮冠状动脉介入治疗

Abstract:

Keywords:

基金项目(Foundation): 解放军总医院第六医学中心创新培育基金项目（CXPY202312）

作者(Author): 王宁远,王威,辛倩,高磊

参考文献(References)：

• [1]Klein LW,Sheldon MW,Brinkep J,et al.The use of radiographic contrast media during PCI:a focused review:a position statement of the Society of Cardiovascular Angiography and Interventions[J].Catheter Cardiovasc Interv,2009,74(5):728-746.DOI:10.1002/ccd.22113.
• [2] Katayama H,Yamaguchi K,Kozuka T,et al.Adverse reactions to ionic and nonionic contrast media.A report from the Japanese Committee on the Safety of Contrast Media[J].Radiology,1990,175(3):621-628.DOI:10.1148/radiology.175.3.2343107.
• [3] Mitchell AM,Jones AE,Tumlin JA,et al.Incidence of contrastinduced nephropathy after contrast-enhanced computed tomography in the outpatient setting[J].Clin J Am Soc Nephrol,2010,5(1):4-9.DOI:10.2215/CJN.05200709.
• [4]Seeliger E,Sendeski M,Rihal CS,et al.Contrast-induced kidney injury:mechanisms,risk factors,and prevention[J].Eur Heart J,2012,33(16):2007-2015.DOI:10.1093/eurheartj/ehr494.
• [5]Azzalini L,Spagnoli V,Ly HQ.Contrast-induced nephropathy:from pathophysiology to preventive strategies[J].Can J Cardiol,2016,32(2):247-255.DOI:10.1016/j.cjca.2015.05.013.
• [6]中华医学会临床药学分会,中国药学会医院药学专业委员会,中华医学会肾脏病学分会.碘对比剂诱导的急性肾损伤防治的专家共识[J].中华肾脏病杂志,2022,38(3):265-288.DOI:10.3760/cma.j.cn441217-20210909-00041.
• [7]Kane GC,Doyle BJ,Lerman A,et al.Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography[J].J Am Coll Cardiol,2008,51(1):89-90.DOI:10.1016/j.jacc.2007.09.019.
• [8]Nyman U,BJ?rk J,Aspelin P,et al.Contrast medium dose-toGFR ratio:a measure of systemic exposure to predict contrastinduced nephropathy after percutaneous coronary intervention[J].Acta Radiol,2008,49(6):658-667.DOI:10.1080/02841850802050762.
• [9]Nayak KR,Mehta HS,Price MJ,et al.A novel technique for ultra-low contrast administration during angiography or intervention[J].Catheter Cardiovasc Interv,2010,75(7):1076-1083.DOI:10.1002/ccd.22414.
• [10] Neumann FJ,Sousa-Uva M,Ahlsson A,et al.2018 ESC/EACTS Guidelines on myocardial revascularization[J].Eur Heart J,2019,40(2):87-165.DOI:10.1093/eurheartj/ehy394.
• [11]Gunn HS,Dixon SR,Smith DE,et al.Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions[J].JAm Coll Cardiol,2011,58(9):907-914.DOI:10.1016/j.jacc.2011.05.023.
• [12]Gurm HS,Seth M,Dixon SR,et al.Contemporary use of and outcomes associated with ultra-low contrast volume in patients undergoing percutaneous coronary interventions[J].Catheter Cardiovasc Interv,2019,93(2):222-230.DOI:10.1002/ccd.27819.
• [13]陆泓雨,陈纪元,贺子熠,等.晚期慢性肾病患者的冠状动脉介入治疗策略[J].中国介入心脏病学杂志,2022,30(10):797-800.DOI:10.3969/j.issn.1004-8812.2022.10.012.
• [14]Hennessey B,Shabbir A,Travieso A,et al.Procedural and technological innovations facilitating ultra-low contrast percutaneous coronary interventions[J].Interv Cardiol,2023,18:e09.DOI:10.15420/icr.2022.32.
• [15]Sacha J,Gierlotka M,Feusette P,et al.Ultra-low contrast coronary angiography and zero-contrast percutaneous coronary intervention for prevention of contrast-induced nephropathy:step-by-step approach and review[J].Postepy Kardiol Interwencyjnej,2019,15(2):127-136.DOI:10.5114/aic.2019.86007.
• [16] Ezhumalai B.The principles of ultra-low contrast percutaneous coronary intervention[J].Indian Heart J,2022,74(3):258-259.DOI:10.1016/j.ihj.2022.04.005.
• [17]Nozue T,Michishita I,Mizuguchi I.Impact of catheter downsizing and power injector use on the amount of contrast medium delivered[J].Cardiovasc Interv Ther,2010,25(1):24-28.DOI:10.1007/s12928-009-0003-6.
• [18]Wang XR,Zhang JJ,Xu XX,et al.Prevalence of coronary artery calcification and its association with mortality,cardiovascular events in patients with chronic kidney disease:a systematic review and meta-analysis[J].Ren Fail,2019,41(1):244-256.DOI:10.1080/0886022X.2019.1595646.
• [19] Kim JK,Kim NH,Shin IS,et al.Alteration of ventricular repolarization by intracoronary infusion of normal saline in patients with variant angina[J].Korean Circ J,2009,39(6):223-227.DOI:10.4070/kcj.2009.39.6.223.
• [20]张颖倩,高磊,陈韵岱,等.CT血管造影结合血管内超声引导无对比剂完成左回旋支重度狭窄介入治疗1例[J].中国介入心脏病学杂志,2022,30(3):238-240,DOI:10.3969/j.issn.1004-8812.2022.03.016.
• [21] Mariani J,Guedes C,Soares P,et al.Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention:the MOZART(Minimizing cOntrast utilization With IVUS Guidance in coRonary angioplasTy)randomized controlled trial[J].JACC Cardiovasc Interv,2014,7(11):1287-1293.DOI:10.1016/j.jcin.2014.05.024.
• [22]Ali ZA,Karimi Galougahi K,Nazif T,et al.Imaging-and physiolo gy-guided percutaneous coronary intervention without contrast administration in advanced renal failure:a feasibility,safety,and outcome study[J].Eur Heart J,2016,37(40):3090-3095.DOI:10.1093/eurheartj/ehw078.
• [23]Sacha J.Marking wire technique for zero-contrast percutaneous coronary interventions[J].Postepy Kardiol Interwencyjnej,2018,14(2):204-205,DOI:10.5114/aic.2018.76416.
• [24] Beyar R,Davies JE,Cook C,et al.Robotics,imaging,and artificial intelligence in the catheterisation laboratory[J].EuroIntervention,2021,17(7):537-549.DOI:10.4244/EIJ-D-21-00145.
• [25] Piayda K,Kleinebrecht L,Afzal S,et al.Dynamic coronary roadmapping during percutaneous coronary intervention:a feasibility study[J].Eur J Med Res,2018,23(1):36.DOI:10.1186/s40001-018-03 3 3-x.
• [26]Yabe T,Muramatsu T,Tsukahara R,et al.The impact of percutaneous coronary intervention using the novel dynamic coronary roadmap system[J].Heart Vessels,2020,35(3):323-330.DOI:10.1007/s00380-019-01502-1.
• [27]胡文瑛,严鹏勇,王睿,等.“零对比剂”经皮冠状动脉介入治疗对重度肾功能不全患者的安全性及有效性分析[J].中国介入心脏病学杂志,2021,29(7):371-374.DOI:10.3969/j.issn.1004-B812.2021.07.002.
• [28]Kumar P,Jino B,Roy S,et al.Absolute zero-contrast percutaneous coronary intervention under intravascular ultrasound guidance in chronic kidney disease patients-From despair to hope?[J].Int J Cardiol Heart Vase,2022,40:101052.DOI:10.1016/j.ij cha.2022.101052.
• [29]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.光学相干断层成像技术在冠心病介入诊疗中应用的中国专家共识[J],中华心血管病杂志,2023,51(2):109-124.DOI:10.3760/cma.j.cn112148-20220602-00436.
• [30]Frick K,Michael TT,Alomar M,et al.Low molecular weight dextran provides similar optical coherence tomography coronary imaging compared to radiographic contrast media[J].Catheter Cardiovasc Interv,2014,84(5):727-731.DOI:10.1002/ccd.25092.
• [31] Azzalini L,Mitomo S,Hachinohe D,et al.Zero-contrast percutaneous coronary intervention guided by dextran-based optical coherence tomography[J].Can J Cardiol,2018,34(3):342.e1-342.e3.DOI:10.1016/j.cjca.2017.11.008.
• [32]Diab OA,Helmy M,Gomaa Y,et al.Efficacy and safety of coronary sinus aspiration during coronary angiography to attenuate the risk of contrast-induced acute kidney injury in predisposed patients[J].Circ Cardiovasc Interv,2017,10(1):e004348.DOI:10.1161/CIRCINTERVENTIONS.116.004348.